CXCR4 and neuroblastoma: Our examination revealed a decrease in surface expression of CXCR4 on medium to high expressing neuroblastoma cells following treatment with lactacystin (Fig. 8B); we speculate that this may be due to decreased proteasomal degradation of a negative regulator of CXCR4 surface expression resulting in enhanced downregulation of surface expression.